DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

Information source: Boehringer Ingelheim
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: Low dose of telmisartan (Drug); High dose of telmisartan (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Boehringer Ingelheim

Summary

Study to assess the effect of Telmisartan on diastolic and systolic blood pressure and to establish the effect on patient's quality of life scores.

Clinical Details

Official title: An Open-label Evaluation of the Effectiveness of MICARDIS« (Telmisartan) on Blood Pressure Control and Quality of Life in Patients With Essential Hypertension The MICARDIS COMMUNITY ACCESS TRIAL (MicCAT)

Study design: Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Change in diastolic blood pressure

Change in systolic blood pressure

Changes from baseline in the quality of life (QOL) scores by patient self-assessment

Secondary outcome:

Assessment of blood pressure control rate

Assessment of systolic blood pressure response rate

Assessment of diastolic blood pressure response rate

Change from baseline in pulse pressure

Number of patients with adverse events

Eligibility

Minimum age: 20 Years. Maximum age: 93 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with Stage I essential Hypertension (diastolic blood pressure 90-99 mmHg,

and/or systolic blood pressure 140-159 mmHg)

- Signed informed consent form

Exclusion Criteria:

- Females of childbearing potential

Locations and Contacts

Additional Information

Starting date: September 1999
Last updated: September 16, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017